Metro
China Junshi's potential COVID drug shows promise in small trial
The drug is undergoing a Phase III trial to evaluate its efficacy in mild to moderate patients in comparison with Pfizer Incs oral pill Paxlovid and a separate Phase III trial in moderate...
2022-05-18 15:30